ArcticZymes Technologies ASALTS:0DRV 77 EV-to-FCF is 32.29 as of Jul. 07, 2026, which is 25% below its 10-year median of 43.28. GuruFocus rates LTS:0DRV with a GF Score™ of 77/100 and a GF Value™ of kr23.88 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 329 Biotechnology companies, ArcticZymes Technologies ASA ranks worse than 68.09% on this metric.
The historical rank and industry rank for ArcticZymes Technologies ASA's EV-to-FCF or its related term are showing as below:
LTS:0DRV'
s EV-to-FCF Range Over the Past 10 Years
Min: -8242.25 Med: 43.28 Max: 355.69
Current: 32.95
During the past 13 years, the highest EV-to-FCF of ArcticZymes Technologies ASA was 355.69. The lowest was -8242.25. And the median was 43.28.
LTS:0DRV's EV-to-FCF is ranked worse than 68.09% of 329
companies
in the Biotechnology industry
Industry Median: 16.38
vs LTS:0DRV: 32.95
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ArcticZymes Technologies ASA's PE Ratio (TTM) for today is calculated as:
ArcticZymes Technologies ASA's share price for today is kr20.90.
ArcticZymes Technologies ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.260.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
ArcticZymes Technologies ASA EV-to-FCF Related Terms
ArcticZymes Technologies ASA EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0DRV vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, ArcticZymes Technologies ASA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ArcticZymes Technologies ASA EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where ArcticZymes Technologies ASA's EV-to-FCF falls into.
ArcticZymes Technologies ASA's current Enterprise Value is kr745.9 Mil.
ArcticZymes Technologies ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr23.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA (LTS:0DRV) has a EV-to-FCF of 32.29 as of Jul. 07, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ArcticZymes Technologies ASA and its competitors. This is 25% below median its historical median of 43.28. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #224 out of 329 companies in the Biotechnology industry, placing it in the top 68.1%.
Is ArcticZymes Technologies ASA's EV-to-FCF too high?
ArcticZymes Technologies ASA's current EV-to-FCF of 32.29 is 25% below median its 10-year median of 43.28. The Biotechnology industry median EV-to-FCF is 16.38. ArcticZymes Technologies ASA's value of 32.29 is 97.1% above this industry median. Based on the distribution chart, ArcticZymes Technologies ASA ranks #224 out of 329 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ArcticZymes Technologies ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #224 out of 329 companies for EV-to-FCF. This places ArcticZymes Technologies ASA in the lower half of its industry. The industry median EV-to-FCF is 16.38. ArcticZymes Technologies ASA's value of 32.29 is 97.1% above this benchmark. While the company's 10-year median is 43.28 vs. the industry median of 16.38, ArcticZymes Technologies ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.38, based on 329 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ArcticZymes Technologies ASA's current EV-to-FCF of 32.29 is 97.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ArcticZymes Technologies ASA and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ArcticZymes Technologies ASA's current EV-to-FCF is 32.29, which is 25% below median its own 10-year median of 43.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr23.88, compared to a current price of kr20.90 — trading 12.5% below its estimated fair value. The current EV-to-FCF is 32.29, which is 25% below median its 10-year median of 43.28 and 97.1% above the Biotechnology industry median of 16.38. ArcticZymes Technologies ASA's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current EV-to-FCF is 32.29 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued.
The current stock price of kr20.90 is trading 12.5% below its estimated GF Value™ of kr23.88.
GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.
Key valuation signals for LTS:0DRV:
EV-to-FCF: 32.29 (25% below median its 10-year median of 43.28)
GF Value™: kr23.88 vs. price of kr20.90 (12.5% below fair value)
Industry Position: 97.1% above the Biotechnology median (#224 of 329)
No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
77GF Score
Get the complete analysis for LTS:0DRV
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0DRV has been successfully added to your 
